230 related articles for article (PubMed ID: 26894297)
1. Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria Endemic Rural Eastern Indonesia.
Satyagraha AW; Sadhewa A; Elvira R; Elyazar I; Feriandika D; Antonjaya U; Oyong D; Subekti D; Rozi IE; Domingo GJ; Harahap AR; Baird JK
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004457. PubMed ID: 26894297
[TBL] [Abstract][Full Text] [Related]
2. Glucose-6-phosphate dehydrogenase deficiency among Yemeni children residing in malaria-endemic areas of Hodeidah governorate and evaluation of a rapid diagnostic test for its detection.
Abdul-Ghani R; Mahdy MA; Saif-Ali R; Alkubati SA; Alqubaty AR; Al-Mikhlafy AA; Al-Eryani SM; Al-Mekhlafi AM; Alhaj A
Malar J; 2016 Jun; 15():327. PubMed ID: 27329471
[TBL] [Abstract][Full Text] [Related]
3. G6PD deficiency at Sumba in Eastern Indonesia is prevalent, diverse and severe: implications for primaquine therapy against relapsing Vivax malaria.
Satyagraha AW; Sadhewa A; Baramuli V; Elvira R; Ridenour C; Elyazar I; Noviyanti R; Coutrier FN; Harahap AR; Baird JK
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003602. PubMed ID: 25746733
[TBL] [Abstract][Full Text] [Related]
4. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.
Roca-Feltrer A; Khim N; Kim S; Chy S; Canier L; Kerleguer A; Tor P; Chuor CM; Kheng S; Siv S; Kachur PS; Taylor WR; Hwang J; Menard D
PLoS One; 2014; 9(12):e116143. PubMed ID: 25541721
[TBL] [Abstract][Full Text] [Related]
5. Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.
Roh ME; Oyet C; Orikiriza P; Wade M; Mwanga-Amumpaire J; Boum Y; Kiwanuka GN; Parikh S
Am J Trop Med Hyg; 2016 Nov; 95(5):1094-1099. PubMed ID: 27672207
[TBL] [Abstract][Full Text] [Related]
6. Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.
Henriques G; Phommasone K; Tripura R; Peto TJ; Raut S; Snethlage C; Sambo I; Sanann N; Nguon C; Adhikari B; Pongvongsa T; Imwong M; von Seidlein L; Day NP; White NJ; Dondorp AM; Newton P; Ley B; Mayxay M
Malar J; 2018 Jun; 17(1):243. PubMed ID: 29929514
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd), CareStart qualitative rapid diagnostic test performance, and genetic variants in two malaria-endemic areas in Sudan.
Ali Albsheer MM; Lover AA; Eltom SB; Omereltinai L; Mohamed N; Muneer MS; Mohamad AO; Abdel Hamid MM
PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009720. PubMed ID: 34699526
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) in a malaria endemic area in Ghana, Africa.
Adu-Gyasi D; Asante KP; Newton S; Dosoo D; Amoako S; Adjei G; Amoako N; Ankrah L; Tchum SK; Mahama E; Agyemang V; Kayan K; Owusu-Agyei S
PLoS One; 2015; 10(4):e0125796. PubMed ID: 25885097
[TBL] [Abstract][Full Text] [Related]
9. Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
Ley B; Winasti Satyagraha A; Rahmat H; von Fricken ME; Douglas NM; Pfeffer DA; Espino F; von Seidlein L; Henriques G; Oo NN; Menard D; Parikh S; Bancone G; Karahalios A; Price RN
PLoS Med; 2019 Dec; 16(12):e1002992. PubMed ID: 31834890
[TBL] [Abstract][Full Text] [Related]
10. Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells.
Baird JK; Dewi M; Subekti D; Elyazar I; Satyagraha AW
Transl Res; 2015 Jun; 165(6):677-88. PubMed ID: 25312015
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia.
Wojnarski B; Lon C; Sea D; Sok S; Sriwichai S; Chann S; Hom S; Boonchan T; Ly S; Sok C; Nou S; Oung P; Kong N; Pheap V; Thay K; Dao V; Kuntawunginn W; Feldman M; Gosi P; Buathong N; Ittiverakul M; Uthaimongkol N; Huy R; Spring M; Lek D; Smith P; Fukuda MM; Wojnarski M
PLoS One; 2020; 15(1):e0228207. PubMed ID: 32004348
[TBL] [Abstract][Full Text] [Related]
12. Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.
Oo NN; Bancone G; Maw LZ; Chowwiwat N; Bansil P; Domingo GJ; Htun MM; Thant KZ; Htut Y; Nosten F
PLoS One; 2016; 11(4):e0152304. PubMed ID: 27035821
[TBL] [Abstract][Full Text] [Related]
13. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
Bancone G; Gornsawun G; Chu CS; Porn P; Pal S; Bansil P; Domingo GJ; Nosten F
PLoS One; 2018; 13(5):e0196716. PubMed ID: 29738562
[TBL] [Abstract][Full Text] [Related]
14. An Evaluation of a New Quantitative Point-of Care Diagnostic to Measure Glucose-6-phosphate Dehydrogenase Activity.
Bahk YY; Ahn SK; Jeon HJ; Na BK; Lee SK; Shin HJ
Korean J Parasitol; 2022 Aug; 60(4):281-288. PubMed ID: 36041490
[TBL] [Abstract][Full Text] [Related]
15. Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria.
Satyagraha AW; Sadhewa A; Panggalo LV; Subekti D; Elyazar I; Soebianto S; Mahpud N; Harahap AR; Baird JK
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009610. PubMed ID: 34270547
[TBL] [Abstract][Full Text] [Related]
16. Real-life implementation of a G6PD deficiency screening qualitative test into routine vivax malaria diagnostic units in the Brazilian Amazon (SAFEPRIM study).
Brito-Sousa JD; Murta F; Vitor-Silva S; Sampaio VS; Mendes MO; Brito MAM; Batista TSB; Santos APC; Marques LLG; Barbosa LRA; Melo MM; Baia-da-Silva DC; Silva-Neto AV; Santos TC; Souza BKA; Figueiredo EFG; Silva EL; Rodovalho S; Nakagawa TH; Arcanjo AR; Siqueira AM; Melo GC; Recht J; Domingo GJ; Bassat Q; Bancone G; Monteiro WM; Lacerda MVG
PLoS Negl Trop Dis; 2021 May; 15(5):e0009415. PubMed ID: 34003840
[TBL] [Abstract][Full Text] [Related]
17. Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.
Kim S; Nguon C; Guillard B; Duong S; Chy S; Sum S; Nhem S; Bouchier C; Tichit M; Christophel E; Taylor WR; Baird JK; Menard D
PLoS One; 2011; 6(12):e28357. PubMed ID: 22164279
[TBL] [Abstract][Full Text] [Related]
18. Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency.
Baird JK
BMC Med; 2015 Dec; 13():296. PubMed ID: 26652887
[TBL] [Abstract][Full Text] [Related]
19. Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon.
Brito MA; Peixoto HM; Almeida AC; Oliveira MR; Romero GA; Moura-Neto JP; Singh N; Monteiro WM; Lacerda MV
Rev Soc Bras Med Trop; 2016; 49(4):446-55. PubMed ID: 27598631
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness Analysis of Sex-Stratified
Devine A; Howes RE; Price DJ; Moore KA; Ley B; Simpson JA; Dittrich S; Price RN
Am J Trop Med Hyg; 2020 Jul; 103(1):394-403. PubMed ID: 32372747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
